NAGE Niagen Bioscience, Inc.
Healthcare · Medicinal Chemicals & Botanical Products
Niagen Bioscience, Inc. (NAGE) is a healthcare company in the Medicinal Chemicals & Botanical Products industry, with a market capitalization of $278 million. Shares last traded at $3.49, 76.2% below their 52-week high. Over the past year the stock is down 74.9%. NAGE trades at a price-to-earnings ratio of 15.99, below the Medicinal Chemicals & Botanical Products median of 24.23. Net profit margin is 13.4%, above the peer median of -4.6%. Revenue grew 29.9% year over year.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q1 2026 | $0.07 | 2026-05-06 |
| FY 2025 | $0.20 | 2026-03-04 |
| Q3 2025 | $0.15 | 2025-11-04 |
| Q2 2025 | $0.10 | 2025-08-06 |
| Q1 2026 | $0.06 | 2026-05-06 |
| FY 2025 | $0.11 | 2026-03-04 |
Medicinal Chemicals & Botanical Products peers
NAGE vs 14 industry peers (Medicinal Chemicals & Botanical Products), by market cap.
| DFTX | Definium Therapeutics, Inc. | $2.7B | — | — | — | +0.14% |
| TRLV | Trulieve Cannabis Corp. | $1.9B | -16.31 | 1.61 | -9.9% | +5.67% |
| TLRY | Tilray Brands, Inc. | $552M | -0.25 | — | — | -0.52% |
| CGC | Canopy Growth Corp | $409M | -1.55 | 1.44 | -92.4% | +2.75% |
| USNA | USANA HEALTH SCIENCES INC | $349M | 32.46 | 0.38 | 1.2% | +2.60% |
| NAGE | Niagen Bioscience, Inc. | $278M | 15.99 | 2.15 | 13.4% | +3.56% |
| FTLF | FITLIFE BRANDS, INC. | $105M | 51.93 | 6.58 | 12.7% | +3.29% |
| BTMD | biote Corp. | $69M | 2.56 | 0.36 | 14.1% | +0.44% |
| NAII | NATURAL ALTERNATIVES INTERNATIONAL INC | $16M | -6.55 | 0.48 | -7.3% | +7.41% |
| MTEX | MANNATECH INC | $11M | -0.71 | 0.10 | -14.1% | +0.54% |
| SNYR | Synergy CHC Corp. | $4M | -0.30 | 0.12 | -40.6% | +20.43% |
| MEHA | Functional Brands Inc. | $788610 | — | — | — | -54.56% |
| ACB | Aurora Cannabis Inc | — | — | — | — | -0.34% |
| IMCC | IM Cannabis Corp. | — | — | — | — | -10.63% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.